SPEAKERS
- 26 - 28 SEPTEMBER 2024
- Mantra Mooloolaba Beach
KEYNOTE SPEAKER
Professor Andy Keeling
Professor Andy Keeling studied computer science in the early nineties at the University of Bristol (UK) before switching to Dentistry, qualifying in 1999.
He worked in full time general practice for a decade before migrating to a full time University position at Leeds School of Dentistry. Over the past 15 years he has built and led the Digital Dentistry Group, with the aim of investigating and developing technological solutions to genuine clinical problems. Current work is focussed on accurately getting the patient into the computer, including 3D scanning, facial scanning, and dynamic articulation. A second strand of work involves 3D printing for dental training models and for dentures. Most of the work involves traditional software engineering combined with machine learning, followed by clinical trials.
Andy is a Senior Consultant for GC IaG (Switzerland) advising on all aspects of digital dentistry. A spin-out company was recently formed in Leeds to develop various outputs from his academic group and has received around GBP 3 million in funding to date from government grants and other investments.
Andy has authored over 50 peer-reviewed academic papers and regularly collaborates with other international groups.
FEATURED SPEAKERS
Don’t miss this opportunity to learn from the collective experience of the Reconnext 2024 faculty of speakers, as they share their insights into delivering world-leading clinical studies and treatments.
Prof Nigel Curtis
Chair of Paediatric Infectious Diseases
Paediatrics Royal Children’s Hospital
Professor Nigel Curtis is a paediatric infectious diseases physician and clinician scientist. He is Professor of Paediatric Infectious Diseases at the University of Melbourne and Head of Infectious Diseases at the Royal Children’s Hospital Melbourne.
He is also Leader of Infectious Diseases & Microbiology Research Group at Murdoch Children’s Research Institute, holds an undergraduate medical degree from the University of Cambridge. He completed clinical training at St Mary’s Medical School, University of London, and lab training at Imperial College London. Specializing in infectious diseases, his research, supported by grants exceeding $35 million, centers on enhancing diagnosis, treatment, and prevention of childhood infectious diseases. He leads a multidisciplinary team and is Chief Principal Investigator of The BRACE Trial, investigating BCG vaccination’s impact on COVID-19 in healthcare workers.